CYTOMEGALOVIRUS VIRAEMIA

Clinical trials for CYTOMEGALOVIRUS VIRAEMIA explained in plain language.

Never miss a new study

Get alerted when new CYTOMEGALOVIRUS VIRAEMIA trials appear

Sign up with your email to follow new studies for CYTOMEGALOVIRUS VIRAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

App vs. standard dose: race to clear dangerous virus in sick kids

Disease control Recruiting now

This study is testing if using a web app to calculate a custom dose of the antiviral drug ganciclovir works better than the standard fixed dose for children with weakened immune systems who have a CMV virus infection. Researchers will compare how many children in each group clear…

Matched conditions: CYTOMEGALOVIRUS VIRAEMIA

Phase: PHASE2 • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

CYTOMEGALOVIRUS VIRAEMIA

Get alerted when new CYTOMEGALOVIRUS VIRAEMIA trials appear

App vs. standard dose: race to clear dangerous virus in sick kids